Discussion: The publication discusses the use of large electronic healthcare databases for drug safety research, specifically focusing on the benefits of these databases for monitoring drug safety after approval. It mentions the Observational Medical Outcomes Partnership (OMOP) and the use of a common data model for merging data from different databases. This suggests that the publication is related to the use of standardized data models and vocabularies, which falls under the category of open community data standards. However, it also discusses the generation of clinical evidence through the use of these databases, which falls under the category of clinical evidence generation. 

Final category: 1. Open community data standards
